Profile
Amy Trevvett is currently the Head of Media Relations at Dicerna Pharmaceuticals, Inc. She previously worked as the Director of Corporate Communications at Sumitomo Pharma America, Inc. and as the VP of Corporate Communications and Investor Relations at Alaunos Therapeutics, Inc.
Amy Trevvett active positions
| Companies | Position | Start |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Public Communications Contact | - |
Former positions of Amy Trevvett
| Companies | Position | End |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Public Communications Contact | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
- Stock Market
- Insiders
- Amy Trevvett
















